The US Food and Drug Administration has given its approval for a Abbreviated New Drug Application (ANDA) by Dr Reddy's Laboratories for the production of its Fexofenadine HCl tablets.
The tablets are generic version of Sanofi-Aventis' Allegra tablets and will be sold over the counter under store brand labels.
AdvertisementDr Reddy's revealed that it had got the approval for the drug on April 12, more than three months after the US District Court of New Jersey had given clearance for the company to manufacture the generic version of Allegra-D 24 in US.
P Strides Arcolab Receives FDA Approval to Market Product Figures Reveal too Many Dental Visits for Patients M
You May Also Like